TW202508584A - 癌性疼痛預防或治療用組成物 - Google Patents

癌性疼痛預防或治療用組成物 Download PDF

Info

Publication number
TW202508584A
TW202508584A TW113118625A TW113118625A TW202508584A TW 202508584 A TW202508584 A TW 202508584A TW 113118625 A TW113118625 A TW 113118625A TW 113118625 A TW113118625 A TW 113118625A TW 202508584 A TW202508584 A TW 202508584A
Authority
TW
Taiwan
Prior art keywords
formula
pain
cancer
pharmaceutically acceptable
group
Prior art date
Application number
TW113118625A
Other languages
English (en)
Chinese (zh)
Inventor
久保恵梨香
山村睦朗
島田昌一
山本雪子
Original Assignee
日商丸石製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商丸石製藥股份有限公司 filed Critical 日商丸石製藥股份有限公司
Publication of TW202508584A publication Critical patent/TW202508584A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW113118625A 2023-05-25 2024-05-20 癌性疼痛預防或治療用組成物 TW202508584A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023-086153 2023-05-25
JP2023086153 2023-05-25

Publications (1)

Publication Number Publication Date
TW202508584A true TW202508584A (zh) 2025-03-01

Family

ID=93589461

Family Applications (1)

Application Number Title Priority Date Filing Date
TW113118625A TW202508584A (zh) 2023-05-25 2024-05-20 癌性疼痛預防或治療用組成物

Country Status (9)

Country Link
EP (1) EP4699608A1 (cg-RX-API-DMAC7.html)
JP (1) JPWO2024242158A1 (cg-RX-API-DMAC7.html)
KR (1) KR20260016503A (cg-RX-API-DMAC7.html)
CN (1) CN121079089A (cg-RX-API-DMAC7.html)
AU (1) AU2024275598A1 (cg-RX-API-DMAC7.html)
IL (1) IL324153A (cg-RX-API-DMAC7.html)
MX (1) MX2025013810A (cg-RX-API-DMAC7.html)
TW (1) TW202508584A (cg-RX-API-DMAC7.html)
WO (1) WO2024242158A1 (cg-RX-API-DMAC7.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459240A1 (fr) 1979-06-21 1981-01-09 Cm Ind Aminopiperidines anorexigenes, procede pour leur preparation, intermediaires dans ledit procede et medicaments qui les contiennent
DE69228017D1 (de) 1991-03-27 1999-02-11 Sanofi Sa Verwendung von 4-Amino-1-(2-Pyridyl)Piperidinen als 5-HT3-Agonisten zur Behandlung und Verhütung von serotoninergen Dysfunktionen
ES2960385T3 (es) * 2017-06-28 2024-03-04 Univ Osaka Tratamiento del dolor con agonista del receptor de serotonina-3

Also Published As

Publication number Publication date
EP4699608A1 (en) 2026-02-25
AU2024275598A1 (en) 2026-01-15
CN121079089A (zh) 2025-12-05
WO2024242158A1 (ja) 2024-11-28
MX2025013810A (es) 2025-12-01
IL324153A (en) 2025-12-01
JPWO2024242158A1 (cg-RX-API-DMAC7.html) 2024-11-28
KR20260016503A (ko) 2026-02-03

Similar Documents

Publication Publication Date Title
US10517841B1 (en) Compositions and methods for treating respiratory depression with fenfluramine
US12128012B2 (en) Ketamine treatment for amyotrophic lateral sclerosis
CN105873580A (zh) 加巴喷丁类化合物与σ受体配体的组合物
KR20170131242A (ko) 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도
US20220096444A1 (en) Prophylactic or therapeutic agent for delirium
TW202308627A (zh) 伴隨著飢餓素抗性之惡病體質的治療劑或預防劑
Yegin et al. Analgesic effects of intrathecal neostigmine in perianal surgery
CN103002893A (zh) 神经障碍性疼痛的治疗药或预防药
KR20260016503A (ko) 암성 동통 예방 또는 치료용 조성물
WO2010110428A1 (ja) 掻痒の予防及び/または治療剤
EP3820472A1 (en) Treatment of the pruritic symptoms of liver disease
JP2024511676A (ja) 術後回復のためのオレキシン2受容体アゴニストの使用
TW202216145A (zh) 伴隨代謝異常之疾病或症候群中的肌力低下症狀之改善劑或預防劑
JP7090344B2 (ja) セロトニン3受容体アゴニストによる疼痛の治療
CA3289710A1 (en) Composition for preventing or treating cancer pain
AU2015363757B2 (en) Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
Mohamed et al. Comparative Study between Analgesic Effects of Intrathecal Administration of Midazolam Versus Tramadol with Bupivacaine for Infra-Umbilical Surgeries
CN101641090B (zh) 莫达非尼在制备治疗多动腿综合征的药物中的应用
EA017090B1 (ru) Комбинация модафинила и 1-{3-[3-(4-хлорфенил)пропокси]пропил}пиперидина
WO2016099394A1 (en) Novel selective delta-opioid receptor agonists useful for the treatment of pain, anxiety and depression.
CN114080221A (zh) 用于减轻疼痛的布洛芬与曲马多的组合
KR20070091317A (ko) 섬유근육통 증후군의 치료를 위한 아세틸 엘 카르니틴의용도
HK40000275B (en) Compounds having melatonin receptor affinity as prophylactic or therapeutic agent for delirium
HK1219669A1 (en) Dosage form containing oxycodone and naloxone
HK1139319A (en) Use of modafinil to treat restless leg syndrome